Wealthspire Advisors (Maryland)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-39
| Closed | -$6K | – | 801 |
|
|
2019
Q1 | $6K | Sell |
39
-16
| -29% | -$2.46K | ﹤0.01% | 1729 |
|
|
2018
Q4 | $6K | Buy |
55
+27
| +96% | +$2.95K | ﹤0.01% | 1642 |
|
|
2018
Q3 | $4K | Sell |
28
-3
| -10% | -$429 | ﹤0.01% | 1882 |
|
|
2018
Q2 | $3K | Sell |
31
-141
| -82% | -$13.6K | ﹤0.01% | 1984 |
|
|
2018
Q1 | $18K | Sell |
172
-96
| -36% | -$10K | ﹤0.01% | 1327 |
|
|
2017
Q4 | $29K | Buy |
268
+24
| +10% | +$2.6K | ﹤0.01% | 1205 |
|
|
2017
Q3 | $26K | Sell |
244
-29
| -11% | -$3.09K | ﹤0.01% | 1203 |
|
|
2017
Q2 | $28K | Hold |
273
| – | – | ﹤0.01% | 1143 |
|
|
2017
Q1 | $25K | Buy |
+273
| New | +$25K | ﹤0.01% | 1010 |
|
|
2016
Q2 | – | Sell |
-85
| Closed | -$6K | – | 1709 |
|
|
2016
Q1 | $6K | Buy |
+85
| New | +$6K | ﹤0.01% | 1295 |
|